Clinical practice guidelines on the diagnosis and treatment of hepatitis C infection in patients with chronic kidney disease

Title: Clinical practice guidelines on the diagnosis and treatment of hepatitis C infection in patients with chronic kidney disease
Edition: Original
Classification: Rapid advice guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: 临床医生,肾脏病科医护
Evidence classification method: GRADE
Development unit: 慢性肾脏病合并丙型肝炎病毒感染诊治多学科专家共识临床实践指南委员会
Registration time: 2022-11-27
Registration number: PREPARE-2022CN780
Purpose of the guideline: 丙型肝炎病毒(hepatitis C virus, HCV)感染在慢性肾脏病(chronic kidney disease, CKD)患者中高发,患者在抗HCV治疗方面具有特殊性。随着直接抗病毒药物(direct acting antiviral agent, DAA)问世并广泛应用于临床,CKD患者合并HCV感染的预后获得了极大的改善。近年来HCV治疗领域进展迅速,多种DAA相继在国内获批上市。为此,我国肾脏病、感染病和肝病专家组在2019年发表的《CKD合并HCV感染诊断和治疗的专家共识临床实践指南》基础上,以国内外临床研究进展为依据,结合现阶段我国实际情况,更新形成了本共识临床实践指南,以期为CKD合并HCV感染患者的规范化诊治提供指导性建议。